Zobrazeno 1 - 10
of 323
pro vyhledávání: '"Dennis A. Moore"'
Autor:
Lu Su, Kellie S. Dalby, Hannah Luehmann, Sussana A. Elkassih, Sangho Cho, Xun He, Lisa Detering, Yen-Nan Lin, Nari Kang, Dennis A. Moore, Richard Laforest, Guorong Sun, Yongjian Liu, Karen L. Wooley
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 13, Iss 4, Pp 1660-1670 (2023)
To expand the single-dose duration over which noninvasive clinical and preclinical cancer imaging can be conducted with high sensitivity, and well-defined spatial and temporal resolutions, a facile strategy to prepare ultrasmall nanoparticulate X-ray
Externí odkaz:
https://doaj.org/article/e7261962bbb84ae9b003fc1dcfe14759
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1483-1489 (2020)
The lead author with clinical stage I malignant pleural mesothelioma, epithelioid type, highly programmed cell death ligand 1 (PD-L1) positive, and BAP1 negative, experienced a prompt and exceptionally favorable response to pembrolizumab monotherapy.
Externí odkaz:
https://doaj.org/article/a4ac580114ce420289dd1bf82587a67a
Publikováno v:
Advances in Neurodevelopmental Disorders. 6:178-183
Objectives To identify, using eye-tracking technology, if readers on the autism spectrum (AS) would exhibit longer mean fixation times during question-answering but similar levels of comprehension accuracy to typically developing (TD) individuals. Me
Autor:
Khalil Choucair, Seth J. Page, Bassam I. Mattar, Christopher S. Dakhil, Nassim H. Nabbout, Jeremy M. Deutsch, Quoc V. Truong, Phu V. Truong, Dennis F. Moore, Michael W. Cannon, K. James Kallail, Joseph A. Moore, Shaker R. Dakhil, Radwan Diab, Syed Kamran, Pavan S. Reddy
Publikováno v:
Clinical breast cancer.
RNA-based genomic risk assessment estimates chemotherapy benefit in patients with hormone-receptor positive (HR+)/Human Epidermal Growth Factor 2-negative (ERBB2-) breast cancer (BC). It is virtually used in all patients with early HR+/ERBB2- BC rega
Publikováno v:
Australasian Journal of Special and Inclusive Education. 45:205-220
Students exhibiting behaviours of concern are at increased risk of poor outcomes during their school years. The implementation of school-wide positive behavioural interventions and supports (SWPBIS) has repeatedly been shown to be an effective, evide
Autor:
Steven C. Goicoechea, Sullivan Smith, Matthew L. Kircher, Dennis M. Moore, Douglas E. Anderson, John P. Leonetti
Publikováno v:
31st Annual Meeting North American Skull Base Society.
Autor:
Marko Ostojic, Angelika Anderson, Margherita Busacca, Katrina J. Phillips, Brett Furlonger, Levita D’Souza, Jasmine Chung, Dennis W. Moore
Publikováno v:
The Educational and Developmental Psychologist. 37:47-55
The effective management of chronic asthma requires long-term adherence to both pharmacotherapy and optimal self-management practices. The use of mobile applications (apps) offer a promising and co...
Autor:
Rebecca Rajasekhar, Michael B. Gluth, Matthew J. Urban, John P. Leonetti, Keri Kwarta, Dennis M. Moore, R. Mark Wiet
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 129:1229-1238
Objectives: Historically, eventual loss of cochlear nerve function has limited patients with neurofibromatosis type 2 (NF2) to auditory brainstem implants (ABI), which in general are less effective than modern cochlear implants (CI). Our objective is
Autor:
Rebecca Fall, Sarah K. Howorth, Binita D. Singh, Angelika Anderson, Brett Furlonger, Dennis W. Moore
Publikováno v:
Review Journal of Autism and Developmental Disorders. 8:3-21
Research was reviewed that focussed on the reading comprehension abilities of students with Autism Spectrum Disorders (ASD). Although single-case experimental design (SCD) is an accepted and widely used way in which to evaluate an evidence-based prac
Autor:
Khalil Choucair, Bassam Ibrahim Mattar, Quoc Van Truong, Travis Koeneke, Phu Van Truong, Christopher Dakhil, Michael W Cannon, Seth Joel Page, Jeremy Michael Deutsch, Eric Carlson, Dennis Frederic Moore, Nassim H Nabbout, K James Kallail, Shaker R Dakhil, Pavan S Reddy
Publikováno v:
The oncologist. 27(3)
Background Liquid biopsy testing offers a significant potential in selecting signal-matched therapies for advanced solid malignancies. The feasibility of liquid biopsy testing in a community-based oncology practice, and its actual impact on selecting